ZEB2 and non-small cell lung carcinoma: We reported that a novel regulatory pathway composed of LINC01296/miR-141-3p/ZEB1-ZEB2 is involved in the metastasis progression of NSCLC and CRC and provides potential biomarkers and therapeutic targets for the diagnosis and treatment of tumor metastasis.